Literature DB >> 8505316

Characterization of wild-type and Ser53 mutant eukaryotic initiation factor 4E overexpression in mammalian cells.

R J Kaufman1, P Murtha-Riel, D D Pittman, M V Davies.   

Abstract

Eukaryotic translation initiation factor 4E (eIF-4E) is one component of the m7G-cap-binding protein complex eIF-4F and is required for cap-dependent translation initiation. The phosphorylation state of eIF-4E correlates with increased activity and a major phosphorylation site resides at serine 53. To further evaluate the role of eIF-4E phosphorylation, eIF-4E wild-type and two Ser53 mutants, Ser53Ala and Ser53Asp, were expressed at high level, representing almost 2% of the total cell protein, by transient transfection of COS-1 monkey cells. 32PO4 metabolic labeling of transfected cells demonstrated both Ser53 mutants were phosphorylated at an alternate serine residue. [35S]Methionine pulse-labeling demonstrated that the wild-type and both Ser53 mutants were equally incorporated into the eIF-4F complex. The effect of wild-type and Ser53 mutant overexpression on cap-dependent translation initiation and internal translation initiation was monitored by cotransfection with an expression vector encoding a dicistronic mRNA for which the 5' cistron is translated in a cap-dependent manner, and the 3' cistron is translated by internal ribosome binding. Unexpectedly, overexpression of the wild-type or either mutant did not affect the efficiency of either cap-dependent or internal initiation. These results demonstrate that phosphorylation of eIF-4E at residue 53 is not required for interaction with p220 and suggest that Ser53 phosphorylation may not be required for cap-dependent translation initiation in this system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form.

Authors:  W B Minich; M L Balasta; D J Goss; R E Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

Review 2.  Signal transduction mechanisms in the regulation of protein synthesis.

Authors:  S J Morley
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

3.  A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis.

Authors:  Xin Chen; Jun Huang; Chunhua Yu; Jiao Liu; Wanli Gao; Jingbo Li; Xinxin Song; Zhuan Zhou; Changfeng Li; Yangchun Xie; Guido Kroemer; Jinbao Liu; Daolin Tang; Rui Kang
Journal:  Nat Commun       Date:  2022-10-23       Impact factor: 17.694

4.  The oncogene eIF4E reprograms the nuclear pore complex to promote mRNA export and oncogenic transformation.

Authors:  Biljana Culjkovic-Kraljacic; Aurélie Baguet; Laurent Volpon; Abdellatif Amri; Katherine L B Borden
Journal:  Cell Rep       Date:  2012-08-16       Impact factor: 9.423

Review 5.  The oncogene eIF4E: using biochemical insights to target cancer.

Authors:  Martin Carroll; Katherine L B Borden
Journal:  J Interferon Cytokine Res       Date:  2013-03-08       Impact factor: 2.607

Review 6.  Posttranscriptional control of gene expression in yeast.

Authors:  J E McCarthy
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  The eukaryotic translation initiation factor eIF4E wears a "cap" for many occasions.

Authors:  Katherine L B Borden
Journal:  Translation (Austin)       Date:  2016-08-10

8.  A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery.

Authors:  Laurent Volpon; Biljana Culjkovic-Kraljacic; Hye Seon Sohn; Alexis Blanchet-Cohen; Michael J Osborne; Katherine L B Borden
Journal:  RNA       Date:  2017-03-21       Impact factor: 4.942

9.  New Insights into the Structure-Function Relationship of the Endosomal-Type Na+, K+/H+ Antiporter NHX6 from Mulberry (Morus notabilis).

Authors:  Boning Cao; Zhongqiang Xia; Changying Liu; Wei Fan; Shuai Zhang; Qiao Liu; Zhonghuai Xiang; Aichun Zhao
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.